Bell Flammandex Capsules.
Natural health product licensed in Canada
- Licence holder
- Bell Lifestyle Products Inc.
- NPN or DIN-HM
- 80043243
- Status
- Inactive licence
- Licence date
- 28 June 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fallopia japonica Source : Racine Potency : 8 Pour cent Resveratrol | 80 milligramme | Not calculated |
| Quercétine-3-ruténoside | 40 milligramme | Not calculated |
| Curcuma longa Source : Racine et rhizome | 200 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Extraction ratio : 2:1 Dry plant equivalent : 200 mg Potency : 45 mg Polyphenols | 100 milligramme | Not calculated |
Non-medicinal ingredients
Eau purifiée, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to aid digestion. Used in herbal medicine as an anti-inflammatory to help relive joint pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking antiplatelet medication or blood thinners. Consult a health care practitioner prior to use if you have gallstones. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. If you are taking any heart or blood pressure medication, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice). Consult a health care practitioner prior to use if you have an iron deficiency.
- Contre-indications
Do not use if you have a bile duct obstruction. Do not use if you are pregnant or breastfeeding. If you are attempting to conceive, do not use this product. Do not use if you have liver disorder.
Source
Official Health Canada record, licence 80043243
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.